Executive Education
Innovation in Healthcare: Transformation Through Technology and Culture

healthcare meeting

In a time of unprecedented transformation, healthcare organizations must find new ways to deliver better patient outcomes. 

The healthcare industry is in a period of unprecedented transformation, as technological advancements, shifting payment models and increasing caregiver burdens challenge even the most forward-thinking organizations. To keep pace with these seismic changes, healthcare organizations, pharma and biotech companies must integrate technology into their organizational culture — a task that demands collaboration, experimentation, and strategic alignment within an organization. But how?

In this program, Fisher faculty and industry experts will educate and inspire participants using examples from some of the world's leading healthcare organizations’ innovative uses of technology and artificial intelligence to meet these challenges and develop business intelligence. Learn from these best practices so you can find strategies that fit your business model and enable you to continue pushing the boundaries of medical excellence.

Program Details

Program dates

January 31-February 1, 2024


Registration Deadline

January 17, 2024

Delivery MethodTwo full days, on campus and online pre-work prior to the time on campus

$1,950 per participant 

Promotions and Available Discounts

  • Discounts are available for Ohio State University employees, OSUWMC employees, Veterans, employees from non-profit organizations and organizations who send three or more employees.  For more information about discounts please contact Meredith Conder at conder.11@osu.edu.
Prospective Participant ProfileThis program is valuable for healthcare leaders, nursing and physician administrators as well as frontline physicians and nurses. Individuals who are working in the healthcare industry such as biotech startups, life sciences, health insurers, Health IT and Accountable Care Organizations may benefit from the strategies discussed during this session. Participants may benefit from having basic knowledge of the US Health care industry.

Course Takeaways

  • Open/Close At the conclusion of the program you will be able to...
    • Understand why and when to innovate
    • Know when to use incremental vs. step-change innovation
    • Understand the difference between centralized vs. distributed innovation
    • Know how to develop a process that supports innovation
    • Process the fear of failure more constructively after hearing from several recent successful innovators who have used technology / AI to disrupt healthcare
    • Assess the importance of credibility, sponsorship, strategy alignment, resources, talent, team culture, change management and adoption to scale to manage the organization’s innovation strategy
    • Understand the importance of regulatory requirements and different reimbursement/revenue models when innovating in healthcare

What You Will EarnExample certificate of completion

Once you successfully complete the program, you will be eligible to receive a certificate of completion from The Ohio State University Fisher College of Business. You may proudly display this certificate in your office or home to showcase your accomplishment. You may also add this certificate to the licenses and certifications section of your LinkedIn profile. This will allow you to showcase your newly acquired experience to your network and stand out in your field.

We also value your commitment to learning, and as a token of appreciation, we offer a 10% discount on future topic-based programs you wish to pursue through Executive Education at Fisher College of Business. We believe that learning is a lifelong journey, and we are proud to be a part of yours.

  • Value for Individual
    • Gain inspiration from Innovators who are using technology to create better healthcare outcomes
    • Hear how the role of generative AI in patient care decision-making is making a positive impact in patient outcomes
    • Understand strategies for collaboration across different groups for resources, new ideas and support
    • Decrease frustration and wasted time and resources by learning how to overcome barriers to innovation
    • How to work with teams when implementing new technologies that may disrupt your operations
    • Understand the difference between innovating and experimenting
    • Learn how to process a fear of failure that is natural for innovators
  • Value for Company
    • Organizations will benefit from participants who have learned how to measure organizational innovation capability, identify gaps in innovation, and when and why to innovate
    • Organizations will learn to structure contracts and collaboration modes when working with strategic partners
    • Organizations will benefit from a revival of motivation to innovate due to an increased understanding of how to deploy AI and use decision-making tools
    • Organizations’  innovators will understand how to manage the organization to lead innovation with a better understanding of the impact of credibility, sponsorship, alignment, resources, talent, team culture, change management and adoption to scale as well as external regulatory and reimbursement/revenue requirements
    • Organizations will benefit from innovators who will understand the relationship between innovation, strategy and operations
    • Organizations will benefit from employees learning how to adopt advanced decision-making technologies and integrate them with physician decision-making

Our Faculty

  • Open/Close Aravind Chandrasekaran, Professor of Operations and Business Analytics

    aravind headshotDr. Aravind Chandrasekaran (AC) is the Fisher Distinguished Professor in Operations and Business Analytics at the Fisher College of Business, The Ohio State University. He received his PhD in Operations and Management Sciences from the University of Minnesota. Dr.Chandrasekaran’s research investigates innovation, learning and knowledge creation issues in a variety of industries including high-tech R&D, manufacturing and health-care delivery. In recent years, he has begun to study the challenges involved in developing patient-centric healthcare models by conducting field experiments in collaboration with several physician and nursing leaders in the United States.  His research has been published in all top OM journals including Management Science, Manufacturing & Service Operations Management (MSOM)Journal of Operations Management, Production and Operations Management, as well as other premier journals including Information Systems Research, Journal of General Internal Medicine, Journal of Surgical Research and Harvard Business Review. His research has won several awards including the 2017 Poets and Quants 40 Under 40 Top Business School Professors in the world, 2012 INFORMS-Industry Studies Best Paper Award, 2013 Carol J. Latta Emerging Leadership Award for Outstanding Early Career Scholar by the Decision Sciences Institute and 2015 Pace Setters Award for Research.

    Dr. Chandrasekaran currently serves as the Associate Dean for Graduate Programs and Executive Education at the Fisher College of Business. He oversees all the graduate programs including Full-time MBA, Working Professional MBA, Specialized Masters as well as executive masters programs including EMBA, the Master of Business in Operational Excellence (MBOE) and non-degree executive education. He has developed several custom teaching and research programs for organizations such as Tata Consultancy Services (TCS), Ford Motor Company and Zimmer. He has won several teaching awards including the 2016 & 2012 Best Outstanding Core Professor Award (WPMBA), as well as the 2013 Pace Setter Award for Teaching Excellence.  

     In terms of external service, Dr. Chandrasekaran currently serves as the Department Editor for the Intervention-Based Research Department at JOM, and Senior Editor at POMS.  He also served as track chairs at several conferences including POMS, INFORMS and DSI. He reviews frequently for several leading academic journals including Management Science, Administrative Science Quarterly, Organization Science, MSOM, Decision Sciences and Journal of Marketing and Health Service Research.

  • Open/Close Scott Howell, Previous Chief Strategy Officer for US Pharmaceuticals at Novartis Pharmaceuticals Corporation

    scott howellScott Howell is previous Chief Strategy Officer for US Pharmaceuticals at Novartis Pharmaceuticals Corporation. In this role, Scott led a Commercial Model Transformation for Novartis, as well as US Business Development & Licensing and the Value Based Pricing & Access team. He also served as a member of the US Pharmaceuticals Executive Committee. 

    Scott joined Novartis in 2017 as VP & Head of Market Access, where he led all areas of market access including pricing and contracting, channel, managed care, hospital systems of care, as well as patient and specialty services. In this role he led very successful turnarounds placing Novartis at the forefront of the industry in these domains in the US. Prior to joining Novartis, Scott was Vice President of Market Access at Jazz Pharmaceuticals, a rare disease and orphan drug company and worked for Cardinal Health as Senior Vice President, Manufacturer and Clinical Services, Specialty Pharmaceuticals.  He also spent a number of years at Genentech where he held a variety of leadership positions in market access and clinical development.  Earlier in his career, Scott was Vice President, Pharmacy Affairs, at Highmark Blue Cross Blue Shield where he led the pharmacy program. Before Highmark, he held a variety of medical affairs and managed care leadership roles at SmithKline Beecham/GlaxoSmithKline.

    Scott began his career as a general internist and worked several years in private practice before entering academic medicine at The Ohio State University. While at Ohio State, Scott also held positions for the university in group practice administration and health plan administration.

    Scott earned his undergraduate degree at Notre Dame and his medical degree at Ohio State. He completed his medical internship and residency and also earned an MBA at Duke University. Scott has been lecturing on health policy and industry strategy for a number of years, primarily in the graduate programs at UC Berkeley, and has co-authored and contributed to a number of industry-related papers. Scott serves on several industry advisory boards and is a recognized thought leader in the area of pharmaceutical product value based pricing and access.

  • Open/Close Matt Scantland, Founder & CEO of AndHealth

    Matt Scantland headshotMatt is the Founder and CEO of AndHealth, a leading digital health company that helps people reverse chronic diseases. AndHealth combines specialty care with the ability to help people address the root causes of their conditions, leading to patient outcomes that haven’t been possible before. AndHealth works with employers and health plans to create dramatic costs savings while enabling employees to thrive at work and in their communities.

    Previously, Matt was Co-Founder and CEO of CoverMyMeds, one of the largest and fastest-growing healthcare technology companies in the United States. CoverMyMeds was the first technology “unicorn” in Ohio when Matt led its sale to McKesson for more than $1.4B in 2017. Matt was ranked as the #14 US CEO of Large Companies by Glassdoor, and the #3 CEO in Healthcare, and CoverMyMeds has thousands of Ohio-based employees at its headquarters.

    Matt was born and raised in Columbus, and is a graduate of The Ohio State University.  Matt currently lives in Upper Arlington with his wife and two children. Matt believes strongly in public service, and he and the people of AndHealth are committed to economic development and civic causes around our state. Matt serves on the Executive Committee of the Columbus Partnership, and is a Board Director for The Columbus Foundation, the Columbus Downtown Development Corporation (CDDC), and InnovateOhio.  Matt supports entrepreneurship and business building through his family’s investment firm Twofold Ventures and as a board director at Orange Barrel Media and IKE Smart Cities.

  • Open/Close David Rushlow, Chair of Family Medicine at the Mayo Clinic

    David Rushlow headshotDr. David R. Rushlow is Chair of Family Medicine for the Mayo Clinic practice in the Midwest and is affiliated with multiple Mayo owned hospitals in the upper Midwest. He also serves as an Assistant Professor of Family Medicine at the Mayo Clinic College of Medicine and Science. A popular speaker at health conferences, he has recently authored “Adoption of AI Algorithm to Detect LV Systolic Dysfunction”, an article appearing in the November 2022 issue of Mayo Clinic Proceedings, where he found clinicians who most frequently followed the recommendations of an artificial intelligence tool were more likely to make important and timely diagnoses to help their patients.

    He received his medical degree from Medical College of Wisconsin and has been in practice for more than 20 years.

Cancellation and Transfer Policy

  • Open/Close Cancellation and Transfer Policy

    All cancellations and transfers must be received in writing. Submit your request via email to Jennie McAndrew at mcandrew.28@osu.edu with the name of the program, followed by “cancellation” or “transfer” in the subject line.

    • Cancellations must be made at least thirty (30) days prior to the first day of the program in order to be eligible for a full refund.
    • Cancellations must be made at least fourteen (14) days prior to the first day of the program in order to be eligible for a 50% refund.
    • Any cancellations made less than fourteen (14) days prior to the first day of the program will forfeit the registration fee.
    • If you for any reason are unable to attend the program, please consider sending someone in your place. Participants can transfer their registration to someone else within their organization at no charge up to 24 hours before the first day of the program.

Jennie McAndrew
Education Program Senior Specialist